Total submissions: 23
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000758023 | SCV000564489 | benign | Cardiomyopathy | 2016-12-15 | reviewed by expert panel | curation | The filtering allele frequency of the c.2769C>T (p.Asn923=) variant in the MYH7 gene is 0.22% (47/16512) of South Asian chromosomes by the Exome Aggregation Consortium (http://exac.broadinstitute.org), which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen Inherited Cardiomyopathy Expert Panel (BA1; PMID:29300372). |
Laboratory for Molecular Medicine, |
RCV000035823 | SCV000059474 | benign | not specified | 2016-01-26 | criteria provided, single submitter | clinical testing | p.Asn923Asn in exon 23 of MYH7: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 0.3% (47/16512) o f South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac .broadinstitute.org; dbSNP rs36211716). |
Gene |
RCV000035823 | SCV000170519 | benign | not specified | 2013-05-29 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000232495 | SCV000284270 | benign | Hypertrophic cardiomyopathy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000243521 | SCV000317996 | likely benign | Cardiovascular phenotype | 2016-07-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV000283423 | SCV000386131 | likely benign | Scapuloperoneal myopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV003320056 | SCV000386132 | likely benign | Myosin storage myopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000232495 | SCV000386133 | likely benign | Hypertrophic cardiomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000308026 | SCV000386134 | likely benign | Dilated Cardiomyopathy, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000344688 | SCV000386135 | likely benign | MYH7-related skeletal myopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000407486 | SCV000386136 | likely benign | Left ventricular noncompaction cardiomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000726617 | SCV000701810 | uncertain significance | not provided | 2016-09-30 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000758023 | SCV000901934 | benign | Cardiomyopathy | 2017-03-01 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000758023 | SCV000911000 | benign | Cardiomyopathy | 2018-04-07 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000035823 | SCV001433193 | benign | not specified | 2020-05-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000726617 | SCV001502195 | likely benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | MYH7: BP4, BP7 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000035823 | SCV002041520 | likely benign | not specified | 2021-11-07 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000726617 | SCV003799353 | benign | not provided | 2022-04-15 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000035823 | SCV001744453 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000035823 | SCV001917933 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000035823 | SCV001926805 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000726617 | SCV001959604 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000035823 | SCV001964196 | benign | not specified | no assertion criteria provided | clinical testing |